In Brief This Week: Almac Diagnostics; Leica, Aperio; GenScript; University of Nebraska | GenomeWeb

NEW YORK (GenomeWeb News) – Almac Diagnostics said this week that it has launched a next-generation sequencing service to its portfolio, which also includes microarray, qPCR, and immunohistochemical offerings. Northern Ireland-based Almac said that the new NGS service will initially use the Illumina MiSeq platform.


Leica Biosystems has entered into a definitive agreement to acquire Aperio, expanding its digital pathology business. Terms of the acquisition were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.